Technology
We eliminate cancer cell by cell

Silver Nanocluster
We start with tiny silver nanoclusters—so small, they are invisible even under a microscope—and wrap them in a layer of DNA. This clever design keeps the particles safe ensuring they won’t harm healthy cells.
Entering the Nucleus
Light Activation
Controlled Impact
Disrupting DNA
Our approach tangles up the cancer cell’s DNA, making it impossible for the cell to survive. This process only affectes the cancer cells, reducing the side effects often seen with other treatments.
Why are we unique?
Unlike traditional treatments that affect both cancerous and healthy cells, our drug is activated only inside cancer cells. By using light to control when and where the treatment occurs, we only attack cancer cells, resulting in fewer side effects and better outcomes for patients.
A Payload to Targeting Therapies
Our drug acts as a universal payload for targeted therapeutics, whether guided by peptides, antibodies, or imaging techniques. This versatility enables both precision targeting and image-guided therapy across a broad spectrum of cancer types.
PDC

Peptide targeting cancer linked to our drug as payload
ADC

Antibody targeting cancer linked to our drug as payload
Standalone Drug

Image targeting cancer combined with local injection
Preclinical research
We performed pre-clinical studies in vitro and in vivo, and are in the middle of collecting more data regarding the efficacy, safety and toxicity of our drug.
In a lab

Lab tests show single cell precision & efficacy
In a mouse

Mice show high safety ceiling (not activated)
You can count on us for using our drug to push the boundaries of what is possible in precision oncology.